Trends of blood pressure control in the US during the COVID-19 pandemic

被引:41
|
作者
Shah, Nishant P. [1 ,2 ]
Clare, Robert M. [1 ]
Chiswell, Karen [1 ]
Navar, Ann Marie [4 ]
Shah, Bimal R. [2 ,3 ]
Peterson, Eric D. [4 ]
机构
[1] Duke Clin Res Inst, Durham, NC USA
[2] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA
[3] Teledoc Hlth, Purchase, NY USA
[4] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA
关键词
SEASONAL-VARIATION; MORTALITY; METAANALYSIS; ASSOCIATION; DISEASE; RISK;
D O I
10.1016/j.ahj.2021.11.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance COVID-19 altered lifestyles and disrupted routine health care. Whether blood pressure (BP) control worsened during COVID-19 is unknown. Objective To understand whether home BP control worsened during COVID-19 across the United States (US) . Design, Setting, and Participants A population-based analysis of home BP data from 72,706 participants enrolled in a digital health hypertension control program. Data was compared before (January 2019 to March 2020) and during (April 2020 to August 2020) COVID-19. Main Outcomes and Measures Monthly mean home BP readings, systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) were quantified before and during the pandemic. Multivariable adjustments were made for age, sex, race, region, and months enrolled. Home BP readings were also classified based on monthly averages and highest home BP readings into risk groups: Stage 2 HTN: BP> = 135 or DBP> = 85; Uncontrolled HTN: SBP >= 145 or DBP >= 95; or Severely uncontrolled HTN: SBP > = 160 or DBP > = 100). Results Overall, 72,706 participants were enrolled in a digital health hypertension program between 1/1/2019 and 8/31/2020. Compared with participants pre-COVID-19 (n = 33,440), those during COVID-19 ( n = 39,266) were of similar age (mean 53.0 +/- 10.7 years vs 53.3 +/- 10.8 years); sex (46% vs 50.6% female) and race (29.1% vs 34.2% non-white). Relative to pre-Covid (Apr-Aug 2019) the mean monthly number of home BP readings rose during COVID-19 (Apr-Aug, 2020), from 7.3 to 9.3 per month (P < .001). During COVID-19, participants had higher monthly adjusted mean SBP (131.6 mmHg vs. 127.5 mmHg, P < .001); DBP (80.2 mmHg vs. 79.2 mmHg, P < .001); and MAP (97.4 mmHg vs. 95.3 mmHg; P < .001). Relative to the pre-pandemic period, during COVID-19 the proportion of participants with a mean monthly BP classified as uncontrolled or severely uncontrolled hypertension also rose, 15% vs 19% and 4% vs 5%, respectively Conclusions and Relevance Based on home BP readings, mean monthly BP rose modestly after COVID-19, despite increased utilization of home monitoring. Further studies are needed to examine the longitudinal effects of the pandemic on cardiovascular disease risk factors, the impact of these on long-term population health.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 50 条
  • [31] National Trends in US Otolaryngology Surgical Volume During the Early COVID-19 Pandemic
    Saraswathula, Anirudh
    Gourin, Christine G.
    Stewart, C. Matthew
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2021, 147 (04) : 397 - 399
  • [32] Gun Violence Trends in US Cities During the Early Phase of the COVID-19 Pandemic
    Hall, Chandler
    Wilson, Nick
    Piquero, Alex R.
    JAMA NETWORK OPEN, 2025, 8 (01)
  • [33] Antibiotic prescribing trends in the US during the first 11 months of the COVID-19 pandemic
    Desai, Karishma
    Arora, Prachi
    Ghanekar, Saurabh
    Johnson, Karin
    Harris, Ilene
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2022, 18 (10): : 3855 - 3859
  • [34] Trends and disparities in deaths among young persons in the US during the COVID-19 pandemic
    Rossen, Lauren M.
    Resendez, Adriana
    Behdin, Amanda
    Louis, Michael St.
    ANNALS OF EPIDEMIOLOGY, 2024, 91 : 37 - 43
  • [35] Trends in the incidence of immunologic and oncologic diseases before and during COVID-19 pandemic in the US
    Tsao, Nicole
    Mor, Anil
    Harikrishnan, Venkatesh
    Sinnott, Sarah-Jo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 203 - 203
  • [36] REMOTE PATIENT MONITORING AND GLYCEMIC CONTROL TRENDS DURING THE COVID-19 PANDEMIC
    Myers, V.
    Nykaza, E.
    Evered, A.
    Clements, M.
    Stem, K.
    Nosrat, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A230 - A230
  • [37] Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study
    Feitosa, Fabiana G. A. M.
    Feitosa, Audes D. M.
    Paiva, Annelise M. G.
    Mota-Gomes, Marco A.
    Barroso, Weimar S.
    Miranda, Roberto D.
    Barbosa, Eduardo C. D.
    Brandao, Andrea A.
    Lima-Filho, Jose L.
    Sposito, Andrei C.
    Coca, Antonio
    Nadruz Jr, Wilson
    HYPERTENSION RESEARCH, 2022, 45 (02) : 364 - 368
  • [38] Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study
    Fabiana G. A. M. Feitosa
    Audes D. M. Feitosa
    Annelise M. G. Paiva
    Marco A. Mota-Gomes
    Weimar S. Barroso
    Roberto D. Miranda
    Eduardo C. D. Barbosa
    Andréa A. Brandão
    José L. Lima-Filho
    Andrei C. Sposito
    Antonio Coca
    Wilson Nadruz
    Hypertension Research, 2022, 45 : 364 - 368
  • [39] BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE PATIENTS IN SANGLAH GENERAL HOSPITAL DURING COVID-19 PANDEMIC
    Kamardi, Stanly
    Jagannatha, Gusti Ngurah Prana
    Pradnyana, I. Wayan Agus Surya
    Yasmin, A. A. Ayu Dwi Adelia
    JOURNAL OF HYPERTENSION, 2021, 39 : E9 - E9
  • [40] Trends in Medical Debt During the COVID-19 Pandemic
    Guttman-Kenney, Benedict
    Kluender, Raymond
    Mahoney, Neale
    Wong, Francis
    Xia, Xuyang
    Yin, Wesley
    JAMA HEALTH FORUM, 2022, 3 (05):